Standpoint Research Downgrades Qualcomm (QCOM) to Hold
QCOM Hot Sheet
Rating Summary:17 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Standpoint Research downgrades Qualcomm (Nasdaq: QCOM) from Buy to Hold.
The firm commented, "QCOM has jumped $8 (25%) since July 1 and has out-performed the S&P-500 by > 2000 bps since 7/1. The shares are now trading at > 17X trailing earnings and 15.7X the EPS consensus for 2011. Given the recent move on an absolute and relative (to the S&P) basis, we are not comfortable leaving our highest rating attached to this name in the near-term. QCOM has a market cap of more than $60 bln – 17X trailing twelve months earnings is fair value for this name given the current environment. The recent good news is priced in at this point. After watching QCOM break $37.90 to the downside yesterday, we are happy to exit here at $39.90."
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
The firm commented, "QCOM has jumped $8 (25%) since July 1 and has out-performed the S&P-500 by > 2000 bps since 7/1. The shares are now trading at > 17X trailing earnings and 15.7X the EPS consensus for 2011. Given the recent move on an absolute and relative (to the S&P) basis, we are not comfortable leaving our highest rating attached to this name in the near-term. QCOM has a market cap of more than $60 bln – 17X trailing twelve months earnings is fair value for this name given the current environment. The recent good news is priced in at this point. After watching QCOM break $37.90 to the downside yesterday, we are happy to exit here at $39.90."
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Barclays Lowers PT and Estimates on Royal Bank of Canada (RY); Coming Off The Bandwagon
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
Create E-mail Alert Related Categories
DowngradesRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
